Olfactomedin 4 immunostaining frequency or expression level is decreased in advanced gastric and colon cancers [4,5,32], indicating that OLFM4 is a valuable marker for prognosis of gastrointestinal tumours. Here, OLFM4 is linked to digestive system neoplasm.